Home
>
National Drug Code (NDC)
>
Docusate Sodium
Docusate Sodium - 0615-0586-39 - (Docusate Sodium)
Drug Information of Docusate Sodium
| Product NDC: | 0615-0586 |
| Proprietary Name: | Docusate Sodium |
| Non Proprietary Name: | Docusate Sodium |
| Active Ingredient(s): | 250 mg/1 & nbsp; Docusate Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Docusate Sodium
| Product NDC: | 0615-0586 |
| Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part334 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20100701 |
Package Information of Docusate Sodium
| Package NDC: | 0615-0586-39 |
| Package Description: | 30 CAPSULE in 1 BLISTER PACK (0615-0586-39) |
NDC Information of Docusate Sodium
| NDC Code | 0615-0586-39 |
| Proprietary Name | Docusate Sodium |
| Package Description | 30 CAPSULE in 1 BLISTER PACK (0615-0586-39) |
| Product NDC | 0615-0586 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Docusate Sodium |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20100701 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
| Substance Name | DOCUSATE SODIUM |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
